| International Research in Infectious Diseases (R01 Clinical Trial Not Allowed)- PAR-20-108 |
R01
|
February 04, 2020 |
August 20, 2022 |
| Getting To Zero—Understanding HIV Viral Suppression and Transmission in the United States (R01, Clinical Trial Optional)- PAR-20-036 |
R01
|
October 24, 2019 |
September 08, 2022 |
| Understanding the Clinical History of Bacterial Sexually Transmitted Infections (STI) to Accelerate Diagnostic and Vaccine Development (R01 Clinical Trial Not Allowed)- RFA-AI-22-034 |
R01
|
May 12, 2022 |
September 13, 2022 |
| Partnerships for Development of Vaccines Against Select Enteric Pathogens (R01 Clinical Trial Not Allowed)- RFA-AI-22-037 |
R01
|
May 10, 2022 |
September 15, 2022 |
| Regenerative Medicine Innovation Projects (RMIP) Clinical Trial Planning Grant (R34 - Clinical Trials Not Allowed) - RFA-HL-23-020 |
R34
|
July 08, 2022 |
October 07, 2022 |
| Understanding Persistent Signs and Symptoms Attributed to Post-Treatment Lyme Disease (R01 Clinical Trial Not Allowed)- RFA-AI-22-046 |
R01
|
July 20, 2022 |
November 10, 2022 |
| Molecular Dynamics of HIV (R01 Clinical Trial Not Allowed)- RFA-AI-22-050 |
R01
|
June 27, 2022 |
December 08, 2022 |
| Notice of Special Interest (NOSI)—Advancing Research for Tickborne Diseases (TBDs)- NOT-AI-20-005 |
R01, R15, R41/R42, R43/R44
|
November 12, 2019 |
January 08, 2023 |
| Notice of Special Interest (NOSI)—Advancing Development of Rapid Point-of-Care Hepatitis C Virus Diagnostics- NOT-AI-20-013 |
R01, R21, R41/R42, R43/R44
|
December 17, 2019 |
January 08, 2023 |
| Notice of Special Interest (NOSI)—Mechanisms of Mycobacterial-Induced Immunity in HIV-Infected and/or Uninfected Individuals To Inform Innovative Tuberculosis Vaccine Design- NOT-AI-20-071 |
R01, R21
|
September 10, 2020 |
January 08, 2023 |
| Notice of Special Interest (NOSI)—Complement in Basic Immunology (CIBI)- NOT-AI-21-008 |
R01, R21
|
February 04, 2021 |
January 08, 2023 |
| Notice of Special Interest (NOSI)—Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities- NOT-MD-22-006 |
R01
|
December 21, 2021 |
January 08, 2023 |
| Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required)- PAR-20-139 |
R01
|
March 13, 2020 |
January 14, 2023 |
| Research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (R01 Clinical Trials Not Allowed)- PAR-20-165 |
R01
|
April 13, 2020 |
March 06, 2023 |
| New Technologies for the In vivo Delivery of Gene Therapeutics for an HIV Cure (R01 Clinical Trial Not Allowed)- RFA-AI-20-076 |
R01
|
October 20, 2020 |
March 18, 2023 |
| Detection of HIV for Self-Testing (R61/R33 Clinical Trial Not Allowed)- PAR-21-070 |
R61/R33
|
November 13, 2020 |
March 18, 2023 |
| Research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (R21 Clinical Trials Not Allowed)- PAR-20-168 |
R21
|
April 13, 2020 |
May 08, 2023 |
| NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)- PA-20-185 |
R01
|
May 05, 2020 |
May 08, 2023 |
| Research Project Grant (Parent R01 Clinical Trial Required)- PA-20-183 |
R01
|
May 05, 2020 |
May 08, 2023 |
| NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)- PA-20-200 |
R03
|
May 07, 2020 |
May 08, 2023 |
| NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)- PA-20-195 |
R21
|
May 07, 2020 |
May 08, 2023 |
| NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required)- PA-20-194 |
R21
|
May 07, 2020 |
May 08, 2023 |
| NIAID Clinical Trial Planning Grant (R34 Clinical Trials Not Allowed)- PAR-20-270 |
R34
|
August 05, 2020 |
May 13, 2023 |
| Countermeasures Against Chemical Threats (CounterACT) Exploratory/Developmental Projects (R21 Clinical Trial Not Allowed)- PAR-20-253 |
R21
|
July 07, 2020 |
May 31, 2023 |
| Exploratory Data Science Methods and Algorithm Development in Infectious and Immune-mediated Diseases (R21 Clinical Trial Not Allowed)- RFA-AI-21-035 |
R21
|
March 17, 2021 |
July 07, 2023 |
